Start Date: 20/12/2017
End Date: 20/12/2017
Cost: 180 / 120
Venue: South Kensington, London
The Royal Marsden NHS Foundation Trust
For more information call 020 7808 2921
or email email@example.com for further information
Immune checkpoint inhibitors represent the dawn of a new era in systemic cancer
therapy and it is clear that immunotherapy agents will play an increasing role in cancer care over the coming years.
This event will provide an overview of cancer immunotherapy, with a focus on the recognition and management of immune-mediated toxicities.
The meeting will have a strong clinical emphasis, aimed at providing delegates with practical guidance that can be utilised in daily practice.
This meeting will be of value to healthcare professionals involved in the delivery
of cancer care including; doctors, nurses, pharmacists and physician associates
working in oncology, acute medicine, emergency medicine, medical specialities
and general practice.
We look forward to seeing you in April.